Health Care Originals builds wearable devices that leverage acoustic technology and AI-driven edge computing to continuously monitor deep organ sounds and detect early signs of respiratory distress, often months before attacks. The company translates proprietary acoustic data into actionable, personalized insights for people with asthma and COPD. Among users, 100% report better sleep, 90% report reduced wheezing, and two-thirds experience zero asthma attacks within six months. HCO reports $5.5M in contracted annual recurring revenue (CARR), a robust IP portfolio of 14 granted and 10 pending patents, and says it is near-term profitable. Co-founder and CEO Sharon Samjitsingh, an asthma survivor, says the company intends to scale and seize a large market opportunity. HCO also offers public participation in its financing via Wefunder and positions its platform to improve patient outcomes while reducing healthcare costs.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2025